MeiraGTx Holdings plc Ordinary Shares
Symbol: MGTX (NASDAQ)
8.64
▲ (2.85%) 0.239
Company Description:
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Key Stats
- Today's Open: $8.311
- Today's High: $8.639
- Today's Low: $8.311
- Today's Volume: 1
- Yesterday Close: $8.4
- Yesterday High: $8.405
- Yesterday Low: $8.1467
- Yesterday Volume: 212.68K
- Last Min Volume: 1
- Last Min High: $8.639
- Last Min Low: $8.311
- Last Min VWAP: $8.311
Company Profile
- Name: MeiraGTx Holdings plc Ordinary Shares
- Website: https://www.meiragtx.com
- Listed Date: 2018-06-08
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001735438
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $675.76M
- Round Lot: 100
- Outstanding Shares: 80.45M
- Asset Type: CS
RECENT FILINGS FOR MGTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-22 | 4 | View |
| 2025-07-22 | 144 | View |
| 2025-07-08 | 4 | View |
| 2025-07-08 | 144 | View |
| 2025-07-02 | 4 | View |
| 2025-06-26 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4/A | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-13 | 10-Q | View |
Latest News on MGTX